Register information Patent

DE file number : 60 2016 064 078.3 (Status: pending/in force, Query started: May 8, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2016 064 078.3
96EP file numberEAKZ16 80 4054.1
86WO file numberWAKZPCT/US2016/034275
97EP publication numberEPN3302501
87WO publication numberWPN2016196173
54Designation/titleTIKOMBINATION AUS EINEM PD-1-ANTAGONISTEN UND CPG-C-TYP-OLIGONUKLEOTID ZUR BEHANDLUNG VON KREBS
51IPC main classICM
(ICMV)
A61K 31/7115 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 39/39 (2006.01), A61K 45/06 (2006.01), A61K 9/00 (2006.01), A61N 5/00 (2006.01), C07K 14/435 (2006.01), A61P 35/00 (2006.01)
22DE application dateDATMay 26, 2016
96EP application dateEATMay 26, 2016
86WO application dateWATMay 26, 2016
43Date of first publicationOTDec 8, 2016
Date of publication of grantPETSep 22, 2021
71/73Applicant/ownerINHMerck Sharp & Dohme LLC, Rahway, NJ, US; TriSalus Life Sciences, Inc., Westminster, CO, US
72InventorINYU, Ying, Palo Alto, California 94304, US; DENKER, Andrew Evan, Ardmore, PA 19003, US; SADEKOVA, Svetlana, Palo Alto, California 94304, US; PHAN, Uyen Truong, Palo Alto, California 94304, US; KASTELEIN, Robert A., Palo Alto, California 94304, US; KAUFMAN, David Ross, North Wales, Pennsylvania 19454, US; COFFMAN, Robert L., Berkeley, California 94710-2753, US; GUIDUCCI, Cristiana, Berkeley, California 94710-2753, US; JANSSEN, Robert S., Berkeley, California 94710-2753, US
74RepresentativeVTRUexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE
Address for service Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201562169309 P
Jun 1, 2015
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201562168449 P
May 29, 2015
Due dateFT
FG
May 31, 2025
Annual fee for the 10th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003302501A1
Searchable text: EP000003302501A1
Original document: EP000003302501B1
Searchable text: EP000003302501B1
Original document: WO002016196173
Searchable text: WO002016196173
43Date of first publicationEVTDec 8, 2016
Date of the first transfer into DPMAregisterEREGTApr 11, 2018
Date of the (most recent) update in DPMAregisterREGTSep 26, 2024
(Show all update days)(Hide all update days)
  • Sep 26, 2024
    • St.36: changed (technical change)
  • Jun 27, 2024; Jun 8, 2024; May 9, 2024; May 2, 2024; Apr 25, 2024; Jun 7, 2023; Feb 16, 2023; Jan 28, 2023; Sep 15, 2022; Aug 11, 2022; May 24, 2022; Feb 17, 2022; Jan 29, 2022; Oct 14, 2021; Sep 3, 2021; Sep 2, 2021
    • Historical data not available for this/these date(s)
  • Apr 11, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Dec 8, 2016  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Apr 11, 2018  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA May 24, 2018 May 24, 2018 Details anzeigen
4 Change of classification Change of IPC main class Jan 22, 2019  Details anzeigen
5 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Sep 22, 2021  Details anzeigen
6 Publications Publication by DPMA of mention regarding EP patent grant Oct 14, 2021 Oct 14, 2021 Details anzeigen
7 New applicant/owner details New applicant/owner details Jan 28, 2022 Mar 10, 2022 Details anzeigen
8 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jun 23, 2022 Sep 15, 2022 Details anzeigen
9 New applicant/owner details New applicant/owner details Jan 27, 2023 Mar 9, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTDec 8, 2016
Date of update of the procedureREGTSep 2, 2021
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTApr 11, 2018
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 24, 2018
Issue numberHN21
YearPJ2018
Publication dateVTMay 24, 2018
Type of publicationPARTBibliographic data
View procedures Change of classification (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTChange of classification
Legal/procedural statusVSTChange of IPC main class
Date of legal/procedural statusVSTTJan 22, 2019
51IPC main classICM
(ICMV)
A61K 31/7115 (2006.01)
51Previous IPC main classICMF
(ICMVF)
A61K 31/7115 (2006.01)
Date of update of the procedureREGTSep 2, 2021
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTSep 22, 2021
Date of update of the procedureREGTSep 2, 2021
View procedures Publications (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTOct 14, 2021
Issue numberHN41
YearPJ2021
Publication dateVTOct 14, 2021
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTOct 14, 2021
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJan 28, 2022
Issue numberHN10
YearPJ2022
Publication dateVTMar 10, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHMerck Sharp & Dohme Corp., Rahway, NJ, US; TriSalus Life Sciences, Inc., Westminster, CO, US
71/73Previous applicant/ownerINHFMerck Sharp & Dohme Corp., Rahway, NJ, US, Surefire Medical, Inc., Westminster, CO, US
Date of update of the procedureREGTFeb 17, 2022
View procedures Procedure relating to EP application (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJun 23, 2022
Issue numberHN37
YearPJ2022
Publication dateVTSep 15, 2022
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTSep 15, 2022
View procedures New applicant/owner details (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJan 27, 2023
Issue numberHN10
YearPJ2023
Publication dateVTMar 9, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHMerck Sharp & Dohme LLC, Rahway, NJ, US; TriSalus Life Sciences, Inc., Westminster, CO, US
71/73Previous applicant/ownerINHFMerck Sharp & Dohme Corp., Rahway, NJ, US, TriSalus Life Sciences, Inc., Westminster, CO, US
Date of update of the procedureREGTFeb 16, 2023